News

HOOKIPA Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead

The agreement grants Gilead exclusive rights to HOOKIPA’s TheraT® and VaxWave® investigational arenavirus-based immunization technologies for the…

Read more

Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate

Valneva announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its chikungunya vaccine candidate, VLA1553. …

Read more

New Managing Director at VBCF

In January 2019, the new Managing Director of the Vienna BioCenter Core Facilities GmbH, Daniele Soroldoni, has started his work. Welcome!

Read more

Austrian-Czech project provides open access to research infrastructure

Call for proposals remains open as long as capacity exists

Read more

VBC Summer School 2019 application deadline: 31 January 2019

The Vienna Biocenter Summer School provides a unique opportunity for approx. 28 undergraduate students to work side-by-side with leading researchers…

Read more

Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance

Strategic collaboration agreement with Sandoz to develop digital anti-infectives platform.

Read more

Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate

Valneva today announced the initiation of the Phase 2 Clinical Development for its leading, unique Lyme disease vaccine candidate VLA15.

Read more

HOOKIPA Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus

The clinical trial will be conducted at approximately 35 centers worldwide and will include a total of 150 male and female patients.

Read more

Large infrastructure project PHENOPlant for phenotyping of crop plants approved

Congrats to the VBCF Plant Sciences Facility! Their FFG FuE Infrastrukturförderung application for a multi-sensor and multi-approach high-throughput…

Read more

New website for Vienna BioCenter

Vienna BioCenter launches a state-of-the-art website that lives up to the innovation and dynamism of this vibrant life science cluster.

Read more